Positron emission tomography 2013 in Germany. Results of the query and current status

• Published in: Nuclear medicine Vol. 54; no. 2; p. 53
• Main Authors: Kotzerke, J, Oehme, L, Grosse, J, Hellwig, D
• Format: Journal Article
• Language: German
• Published: Germany 2015
• Subjects: Germany - epidemiology; Humans; Multimodal Imaging - utilization; Neoplasms - diagnostic imaging; Positron-Emission Tomography - utilization; Practice Patterns, Physicians' - statistics & numerical data; Radiopharmaceuticals; Surveys and Questionnaires; utilization review; numerical data; utilization statistics; Positron emission tomography
• ISSN: 0029-5566
• DOI: 10.3413/Nukmed-2015020001

Five years after the first survey the positron emission tomography (PET) council of the German Society of Nuclear Medicine (DGN) repeated a survey to re-evaluate the status of PET diagnostics in Germany based on the data of the year 2013. A web-based questionnaire was used for gathering information retrospectively. Details regarding the physicians involved in PET operations, PET systems, and radiopharmaceuticals were also part of the survey as well as indications and number of studies. Furthermore, the role of PET and PET/CT within the diagnostic process was evaluated. In addition, official statistical hospital reports were analysed. Responses from 52 sites were analysed. They reported a total of 38,350 PET studies in 2013. In the majority of cases PET was used in oncologic indications (87%). Further main applications were: neurology 6%, cardiology 1%, and inflammation 5%. University or other hospitals performed 85% of the studies. The portion of in-patients was 26%. Hybrid systems (56 PET/CT, 5 PET/MRT, and 2 stand-alone PET) were most frequently used for imaging. The radiotracers were labelled with F-18 in 90% of the studies, whereas Ga-68 was used in 9% and C-11 in 1%. Lung tumours were the most investigated tumour entity (40%), followed by malignant lymphoma (8%), tumours of the gastrointestinal tract (5%), and NET (5%). 20% of the 333 physicians hold a PET certificate awarded by the DGN. More than 50% of the facilities were certified according ISO9001, KTQ or QEP standard. The findings of nearly 60% of the oncological studies were discussed interdisciplinary in a tumour board. In federal statistical reports a 56% increase of in-patient PET operations during 5 years was found. In Germany, a moderate increase (9% per year) of PET studies is observed, but compared with other industrialised countries PET is still less established.